Rationale: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 is based on an ABCD assessment tool of symptoms and exacerbation history and grade 1–4 of airflow limitation severity, facilitating classification either into 4 groups (ABCD) or 16 groups (1A-4D). We aimed to compare the GOLD 2011, GOLD 2017 ABCD, and GOLD 2017 1A-4D classifications in terms of their distribution and prediction of mortality and hospitalizations. Methods: In the GenKOLS study, 912 COPD patients with FEV1 less than 80% of the predicted answered questionnaires and performed lung function testing in 2003–2005. The patients were recruited from a hospital patient registry (n=662) and from the general population (n=250), followed up until 2011 with r...
In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading syst...
Evidence for the effectiveness of the new multidimensional GOLD (Global Initiative for Chronic Obstr...
BACKGROUND: The 2013 GOLD classification system for COPD distinguishes four stages: A (low symptoms,...
Rationale: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 is based on an ABC...
Purpose: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published three class...
Purpose: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published three class...
In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading syst...
Marcos Hernández, Gabriel García, Jimena Falco, Agustín R García, Vanina...
SummaryStudy objectivesThe aim of this analysis was to understand the implications of the GOLD 2011 ...
Introduction: The Global Organization of Lung Disease (GOLD) classifies patients with chronic obstru...
Jin Hwa Song,1 Chang-Hoon Lee,1 Soo-Jung Um,2 Yong Bum Park,3 Kwang Ha Yoo,4 Ki Suck Jung,5 Sang-Do ...
Meng-Zhi Han,1,2 Tzuen-Ren Hsiue,3 Sheng-Han Tsai,1 Tang-Hsiu Huang,2,3 Xin-Min Liao,2,3 Chiung-Zuei...
Seung Jun Lee,1 Sang Suk Yun,1 Sunmi Ju,1 Jung Wan You,1 Yu Ji Cho,1 Yi Yeong Jeong,1 Ju-Young Kim,2...
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease. The severity grading system...
Hiang Ping Chan,1,2 Amartya Mukhopadhyay,1,2 Pauline Lee Poh Chong,1,2 Sally Chin,1,2 Xue Yun Wong,1...
In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading syst...
Evidence for the effectiveness of the new multidimensional GOLD (Global Initiative for Chronic Obstr...
BACKGROUND: The 2013 GOLD classification system for COPD distinguishes four stages: A (low symptoms,...
Rationale: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 is based on an ABC...
Purpose: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published three class...
Purpose: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published three class...
In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading syst...
Marcos Hernández, Gabriel García, Jimena Falco, Agustín R García, Vanina...
SummaryStudy objectivesThe aim of this analysis was to understand the implications of the GOLD 2011 ...
Introduction: The Global Organization of Lung Disease (GOLD) classifies patients with chronic obstru...
Jin Hwa Song,1 Chang-Hoon Lee,1 Soo-Jung Um,2 Yong Bum Park,3 Kwang Ha Yoo,4 Ki Suck Jung,5 Sang-Do ...
Meng-Zhi Han,1,2 Tzuen-Ren Hsiue,3 Sheng-Han Tsai,1 Tang-Hsiu Huang,2,3 Xin-Min Liao,2,3 Chiung-Zuei...
Seung Jun Lee,1 Sang Suk Yun,1 Sunmi Ju,1 Jung Wan You,1 Yu Ji Cho,1 Yi Yeong Jeong,1 Ju-Young Kim,2...
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease. The severity grading system...
Hiang Ping Chan,1,2 Amartya Mukhopadhyay,1,2 Pauline Lee Poh Chong,1,2 Sally Chin,1,2 Xue Yun Wong,1...
In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading syst...
Evidence for the effectiveness of the new multidimensional GOLD (Global Initiative for Chronic Obstr...
BACKGROUND: The 2013 GOLD classification system for COPD distinguishes four stages: A (low symptoms,...